Target (CBDY) EBIT Margin (2016 - 2026)
Target (CBDY) reported EBIT Margin of 35.24% for Q1 2026, down 4620.0% year-over-year from 0.78% in Q1 2025, and down 0.89% quarter-over-quarter from 34.93% in Q4 2025.
Target (CBDY) EBIT Margin (2016 - 2026) Analysis & Trends
Target (CBDY) has 10 years of EBIT Margin data on file, last reported at 35.24% in Q1 2026.
- EBIT Margin for Q1 2026 came in at 35.24%, down 4620.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 20.39% (down 3948.0% YoY), and the FY2025 annual result was 5.71%, down 2265.0% from the prior year.
- EBIT Margin retreated to 35.24% in Q1 2026 per CBDY's latest filing, from 34.93% in the prior quarter.
- Over five years, EBIT Margin peaked at 39.61% in Q2 2024 and troughed at 51.17% in Q3 2025.
- A 5-year average of 1.23% and a median of 7.16% in 2022 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin jumped 7968 bps in 2022, then plunged 5337 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 28.91% in 2022, then slumped by 86 bps to 4.0% in 2023, then soared by 361 bps to 18.44% in 2024, then tumbled by 289 bps to 34.93% in 2025, then fell by 1 bps to 35.24% in 2026.
- Business Quant data shows CBDY's EBIT Margin at 35.24% in Q1 2026, 34.93% in Q4 2025, and 51.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Target | - | - | 191,787.00 | -35.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.24% |
| Dec 31, 2025 | -34.93% |
| Sep 30, 2025 | -51.17% |
| Jun 30, 2025 | 11.01% |
| Mar 31, 2025 | 10.97% |
| Dec 31, 2024 | 18.44% |
| Sep 30, 2024 | -43.94% |
| Jun 30, 2024 | 39.61% |
| Mar 31, 2024 | 5.79% |
| Dec 31, 2023 | 4.00% |
| Sep 30, 2023 | -5.40% |
| Jun 30, 2023 | -14.59% |
| Dec 31, 2022 | 28.91% |
| Sep 30, 2022 | 17.97% |
| Jun 30, 2022 | 20.37% |
| Mar 31, 2022 | 8.52% |
| Dec 31, 2021 | -50.77% |
| Mar 31, 2020 | -1,935.10% |
| Mar 31, 2018 | 107,479.47% |
| Dec 31, 2017 | -274,981.32% |